The Pharma Letter | Asia-Pacific non-small cell lung cancer therapeutics market to reach $2.9 ... Times of India MUMBAI: The non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region — Australia, China, India and Japan is expected to increase moderately over the coming years, climbing from $1.8 billion in 2012 to $2.9 billion ... MarketReserachReports.com: Non-Small Cell Lung Cancer Therapeutics Market ... |
